Literature DB >> 33959818

Cord blood levels of interleukin-10 decrease in neonates with increased birth weight: novel implications of the cytokine network in early obesity.

Lucía Angélica Méndez-García1, Halili Minor-Borrego1, Ana Laura Sánchez-Del Real1, José Alfredo Aguayo-Guerrero1, Tania Alvarado-Monroy1, Fernanda Trejo-Millán1, Jahaziel Rosas-Salinas1, Salma Alejandra Rizo-Tellez1,2, Sergio Islas-Andrade1, Juan Carlos Briones-Garduño3, José Manuel Fragoso4, Galileo Escobedo5.   

Abstract

Interleukin-10 (IL-10) and interferon-gamma (IFN-gamma) are associated with body weight alterations in children, adolescents, and adults. However, little is known regarding the role of IL-10 and IFN-gamma in birth weight of neonates. One hundred eighty-two infants were enrolled and divided in groups of normal birth weight (< 95th percentile) or increased birth weight (> 95th percentile) for gestational age. IL-10 and IFN-gamma levels were measured in umbilical cord tissue and blood of newborns by quantitative polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assay (ELISA). The average value of birth weight in infants below and above the 95th percentile was 3.03±0.39 and 3.58±0.37 kg, respectively, and was independent of the mother's pre-gestational body mass index. The Student t test revealed that neonates with birth weights > 95th percentile show a significant 30% decrease in cord blood values of IL-10 as compared to infants with birth weights < 95th percentile (P<0.0001), with no significant changes in IFN-gamma levels (P=0.1661). Cord blood IL-10 was not of maternal origin but produced by umbilical cord tissue that showed less IL-10 expression in neonates with birth weights > 95th percentile than in infants with birth weights < 95th percentile (P=0.0252). Cord blood levels of IL-10 exhibited significant inverse correlations with birth weight (r = - 0.658, P=0.002) and INF-gamma (r = - 0.502, P=0.005).
Conclusion: In conclusion, this work demonstrates for the first time that cord blood IL-10 decreases as birth weight increases in infants born at term and might help to improve early recognition of newborns at higher risk of developing obesity in childhood or adulthood. What is Known: • Reduction in interleukin-10 levels has been associated with obesity in adolescents and adults but not newborns. • The number of neonates with excess birth weight has alarmingly increased in the last 30 years. What is New: • We demonstrate that umbilical cord blood levels of interleukin-10 clearly decrease as birth weight increases. • Interleukin-10 and interferon-gamma integrate a cytokine network that might play a role in obesity in infants.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Birth weight; IFN-gamma; IL-10; Infant; Obesity

Mesh:

Substances:

Year:  2021        PMID: 33959818     DOI: 10.1007/s00431-021-04104-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  35 in total

Review 1.  Role of innate and adaptive immunity in obesity-associated metabolic disease.

Authors:  Tracey McLaughlin; Shelley E Ackerman; Lei Shen; Edgar Engleman
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways.

Authors:  Irving L M H Aye; Susanne Lager; Vanessa I Ramirez; Francesca Gaccioli; Donald J Dudley; Thomas Jansson; Theresa L Powell
Journal:  Biol Reprod       Date:  2014-04-23       Impact factor: 4.285

3.  Serum hepcidin levels and iron metabolism in obese children with and without fatty liver: case-control study.

Authors:  Fatih Demircioğlu; Gökhan Görünmez; Emine Dağıstan; Sevil Bilir Göksügür; Mervan Bekdaş; Mehmet Tosun; Betül Kızıldağ; Erol Kısmet
Journal:  Eur J Pediatr       Date:  2014-02-07       Impact factor: 3.183

4.  Association of low interleukin-10 levels with the metabolic syndrome in obese women.

Authors:  Katherine Esposito; Alessandro Pontillo; Francesco Giugliano; Giovanni Giugliano; Raffaele Marfella; Gianfranco Nicoletti; Dario Giugliano
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

5.  IL-6, IL-8 and IL-10 levels in healthy weight and overweight children.

Authors:  Charmaine S Tam; Sarah P Garnett; Christopher T Cowell; Leonie K Heilbronn; Jennifer W Lee; Melanie Wong; Louise A Baur
Journal:  Horm Res Paediatr       Date:  2010-02-09       Impact factor: 2.852

6.  Inflammatory cytokines in general and central obesity and modulating effects of physical activity.

Authors:  Frank M Schmidt; Julia Weschenfelder; Christian Sander; Juliane Minkwitz; Julia Thormann; Tobias Chittka; Roland Mergl; Kenneth C Kirkby; Mathias Faßhauer; Michael Stumvoll; Lesca M Holdt; Daniel Teupser; Ulrich Hegerl; Hubertus Himmerich
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 7.  Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes.

Authors:  Craig S Nunemaker
Journal:  J Diabetes Res       Date:  2016-10-23       Impact factor: 4.011

8.  Chronic Low-Grade Inflammation in Childhood Obesity Is Associated with Decreased IL-10 Expression by Monocyte Subsets.

Authors:  Rafael T Mattos; Nayara I Medeiros; Carlos A Menezes; Rafaelle C G Fares; Eliza P Franco; Walderez O Dutra; Fabrício Rios-Santos; Rodrigo Correa-Oliveira; Juliana A S Gomes
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

9.  IL-10/STAT3 is reduced in childhood obesity with hypertriglyceridemia and is related to triglyceride level in diet-induced obese rats.

Authors:  Yuesheng Liu; Dong Xu; Chunyan Yin; Sisi Wang; Min Wang; Yanfeng Xiao
Journal:  BMC Endocr Disord       Date:  2018-06-13       Impact factor: 2.763

10.  Elevations of inflammatory proteins in neonatal blood are associated with obesity and overweight among 2-year-old children born extremely premature.

Authors:  Eliana M Perrin; T Michael O'Shea; Asheley Cockrell Skinner; Carl Bose; Elizabeth N Allred; Raina N Fichorova; Jelske W van der Burg; Alan Leviton
Journal:  Pediatr Res       Date:  2018-01-10       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.